Biological E. Limited, commonly referred to as Biological E., is a prominent biopharmaceutical company headquartered in India. Established in 1953, the company has made significant strides in the vaccine and biologics sector, focusing on the development, manufacturing, and marketing of vaccines and therapeutic proteins. With a strong operational presence across various regions, Biological E. has positioned itself as a key player in the global vaccine market. The company is renowned for its innovative products, including a range of vaccines that cater to both infectious diseases and public health needs. Notable achievements include collaborations with international organisations and a commitment to affordable healthcare solutions. With a legacy of quality and a robust pipeline, Biological E. continues to enhance its market position, contributing to global health initiatives and advancing vaccine accessibility.
How does BIOLOGICAL E's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
BIOLOGICAL E's score of 6 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2019, BIOLOGICAL E reported total carbon emissions of approximately 15,132,780 kg CO2e from Scope 1 and about 32,896,560 kg CO2e from Scope 2. This marked an increase from 2018, where emissions were about 13,450,950 kg CO2e for Scope 1 and approximately 29,340,110 kg CO2e for Scope 2. The data indicates a significant rise in emissions over the years, with 2016 showing the highest combined emissions of about 136,784,000 kg CO2e from both scopes. Despite the increasing emissions, there are currently no publicly disclosed reduction targets or climate pledges from BIOLOGICAL E. The absence of specific initiatives or commitments highlights a potential area for improvement in their climate strategy. As the company is headquartered in India, it operates within a rapidly evolving regulatory and environmental landscape, which may influence future commitments to carbon reduction and sustainability practices.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2016 | 2017 | 2018 | 2019 | |
---|---|---|---|---|
Scope 1 | 74,680,000 | 0,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 62,103,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
BIOLOGICAL E is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.